Figure 3

From: Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma

Figure 3

Regression of ARO/cannabinoid 2 receptor (CB2) tumor upon JWH133 treatment. Tumors were induced in six groups of nude mice (10 in each group) by subcutaneous flank injection of 2 × 106 ARO or ARO/CB2 cells. When tumors reached an average size of 250 mm3, animals received daily intratumoral injection of 50 μg ml−1 of JWH133 or vehicle for 3 weeks. At 60 days following inoculation, the tumors were removed and weighed. Data are presented as mean±s.e.m. of tumor weight.